PNTG Stock Analysis: Buy, Sell, or Hold?
PNTG - The Pennant Group, Inc. Common Stock
$36.90
1.31 (3.68%)
▲
5d:
+3.27%
30d:
+20.83%
90d:
+18.42%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Get Alerted When PNTG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: PNTG is 9.0% above its trading range ($33.85). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: PNTG is 9.0% above its trading range ($33.85). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$56.60
Based on 10.8% avg growth
INTRINSIC VALUE TODAY
$35.15
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PNTG is currently trading at $36.90, which is considered extended relative to its 30-day fair value range of $29.55 to $33.85. The stock's valuation (Forward PE: 23.2) is in line with its historical norms (21.4). At these levels, the market is pricing in 2.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, PNTG is in a uptrend. The price is approaching resistance at $37.54. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: PNTG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PNTG is in a uptrend. The price is approaching resistance at $37.54. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: PNTG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$29.55 -
$33.85
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.2%
All Signals
- BEARISH: Price extended above range (+9.0% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.7%)
- NEUTRAL: Near Wall St target ($40.33)
- NEUTRAL: Market pricing in 2.8% annual earnings growth - fairly valued
- CAUTION: Extended 9.0% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$29.55 -
$33.85
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$2.29
(6.2%)
Support & Resistance Levels
Support Level
$30.26
Resistance Level
$37.54
Current Trend
Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.19
Wall Street Target
$40.33
(+9.3%)
Revenue Growth (YoY)
36.0%
Earnings Growth (YoY)
9.1%
Profit Margin
3.0%
Valuation Premium vs History
+2.8% premium
PE vs Historical
23.2 vs 21.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.8%
(market-implied from PE analysis)
1-Year Target
$37.93
(+3%)
2-Year Target
$39.00
(+6%)
3-Year Target
$40.09
(+9%)
3-Yr Target (if PE normalizes)
(PE: 23→21)
PE COMPRESSION
$37.00
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.2, Growth: 17.6%)
$60.06
(+63%)
Base:
(SPY PE: 22.0, Growth: 17.6%)
$57.09
(+55%)
Bear:
(PE: 18.7, Growth: 17.6%)
$48.52
(+32%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (41x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Trailing PE: 41.38 | Current EPS (TTM): $0.86
Bull Case
$72.44
(+96%)
Analyst growth 85.0%, PE expands to 45.5
Base Case
$65.86
(+79%)
Market implied 85.0%, PE stable at 41.4
Bear Case
$24.20
(-34%)
Severe decline -20.0%, PE contracts to 35.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 14, 2026 8:17 PM ET
Data refreshes hourly during market hours. Next update: 9:17 PM
Data refreshes hourly during market hours. Next update: 9:17 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PNTG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$513 | 66 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$246 | 59 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 62 BUY |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$21 | 63 BUY |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$30 | 62 BUY |
